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Abstract
Background: Monozygotic twin pairs who are genetically identical would be potentially useful in
gene expression study for specific traits as cases and controls, because there would be much less
gene expression variation within pairs compared to two unrelated individuals. However the twin
pair has to be discordant for the particular trait or phenotype excluding those resulting from
known confounders. Such discordant monozygotic twin pairs are rare and very few studies have
explored the potential usefulness of this approach.
Results:  We studied genome-wide gene expression in primary osteoblast-like culture from
marrow aspirates obtained from three pairs of monozygotic twins. We used the latest Affymetrix
microchip contains probe sets for more than 20,000 genes. Two pairs were discordant for bone
mineral density at the hip by more than one standard deviation, and the third pair was unrelated
concordant and used as control. Only 1.5% on average of genes showed variation in expression
within pairs as compared to 5% between pairs or over 15% from the literature. Importantly we
identified several groups of genes showing variations within the discordant pairs and not within the
concordant pair such as chondroitin beta 1,4 N-acetylgalactosaminyltransferase, inhibin beta A,
interleukin 1 beta and colony stimulating factor 1 macrophage. These genes are known to have
potential roles in bone physiology relating to bone density, osteoporosis and osteoarthritis.
Conclusion: Using the example of osteoblast-like cells in our monozygotic discordant twins for
osteoporosis, we identified genes showing differential expression. Although without further
experiment, we cannot confirm or conclude these are genes definitely related to bone physiology,
we believe we have shown the potential and cost-effectiveness of further gene expression studies
in discordant monozygotic twin pairs. A replication study for confirmation is essential.
Background
Studies of gene expression in humans have been problem-
atic due to wide individual variation between subjects and
random noise [1]. Characteristically screening studies of
genome-wide expression in cases and controls have pro-
duced in excess of 500 genes of interest to study further.
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These numbers are unfeasible to study in humans and bet-
ter efficient methods are sought to narrow down the
number of gene targets. One potential solution is using
pairs of identical twins, discordant for specific complex
traits or diseases, which has yet to be properly explored.
As an example of a complex trait we chose osteoporosis, a
common condition resulting in fractures and affecting
one in four women in developed countries [2]. One of the
main risk factors for fracture is reduced bone mineral den-
sity (BMD), which is easily measured by Dual Energy X-
ray Absorbtiometry (DXA). Twin studies have consistently
found bone density to be strongly heritable with most
estimates in the range of 70–80% [3], whilst only a small
amount of variance was due to unique environmental
influences.
There are only a handful cellular gene expression studies
reported in monozygotic (MZ) twins [4-8] and just two of
them using microchips for expression study [6,7]. One
study has looked at genome-wide gene expression
changes in lympoblastoid cell lines derived from unre-
lated individuals and MZ twins [8]. The main aim of this
study was to reveal the normal expression variation of
5184 genes in unrelated individuals, and MZ twins were
used to compare the variability of 5 selected highly varia-
ble genes, as expected MZ twins showed much less varia-
tion [8]. Recently, Munshi et al reported genome-wide
gene expression differences between one pair of MZ dis-
cordant for multiple myeloma in peripheral blood mono-
nuclear cells using the Affymetrix hu95av2 arrays, which
covers 12,600 genes.
The aims of our study were therefore to explore the feasi-
bility and value of using the identical twin model to
uncover altered expression of key genes in the tissue of rel-
evance to a common complex trait. We examined and
compared the mRNA expression in primary osteoblast-
like cells of three pairs of monozygotic female twins, two
of which were discordant for bone density, and one pair
concordant for bone density acted as a control.
Results
From 200 MZ pairs screened with DXA, ten were identi-
fied as discordant and 7 excluded for environmental con-
founders. Two MZ pairs were consented for study; their
bone mineral densities (BMD) at the hip were different by
at least 1SD with no obvious environmental cause. These
2 MZ twin pairs (2A/2B and 3A/3B with hip BMD T-score
differed by 1.42 and 1.40 SDs respectively) were the case
pairs, whereas the concordant pair (1A/1B differed by
only 0.14 SD) was used as the control pair. For case pair
3A/3B, T-score also differed by 2.40 for spine BMD. For
convenience of comparison, 1A, 2A and 3A have lower
BMD. All three pairs of MZ twins were of the same age (all
born in 1930), post-menopausal, and had similar body
mass index (BMI) (Table 1).
Primary osteoblast-like cell culture was established from
bone marrow precursor cells. The cell differentiation was
assessed by the expression of osteogenic marker such as
alkaline phosphatase (ALP) and stromal cell marker
STRO1 demonstrated by flow cytometric analysis (data
not shown), also more than half of the colonies were
stained positive with ALP. No sub-culture or passage has
been carried out.
In each of the 6 microchips, the mRNA in the samples
hybridized to about half of the probe sets. From the com-
parison results with MAS5 using a nominal 2 fold cut-off,
there were 417 and 283 probe sets showing at least a 2
fold decrease or increase in expression respectively within
the concordant control pair, 1A/1B (Table 2). The respec-
tively decrease or increase probe sets for the discordant
case pairs were 90 and 45 for 2A/2B pair and 133 and 59
for 3A/3B (Table 2). In total, there were 700, 135 and 192
probe sets changes in 1A/1B, 2A/2B and 3A/3B
respectively, or 3.1%, 0.6% and 0.9% of the total probe
sets. Of particular note is that one probe set showed
Table 1: Bone mineral density (BMD) and T score of the 3 pairs of MZ twins.
Sample Year of Birth BMI* Hip BMD T Score Spine BMD T Score
Concordant pair
1A 1930 22.5 0.6545 -2.67 0.8313 -1.96
1B 1930 23.1 0.6373 -2.81 0.8861 -1.46
Discordant pairs
2A 1930 24.5 0.6992 -2.30 0.8844 -1.48
2B 1930 22.3 0.8692 -0.88 0.9358 -1.01
3A 1930 24.6 0.6473 -2.73 0.8236 -2.03
3B 1930 22.8 0.8145 -1.33 1.0881 +0.37
* BMI: body mass indexBMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/14
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Table 2: Numbers of probe sets showed either decrease of increase in gene expression comparing within and between the MZ pairs. 
2A/2B and 3A/3B are the discordant pair for BMD, and 1A/1B is the concordant pair.
Comparison Changes No. of probe (% of total)
Twin 1B 2B 3B
Within pair Decrease* 1A 417 (1.8%)
2A 90 (0.4%)
3A 133 (0.6%)
Twin 1B 2B 3B
Increase* 1A 283 (1.3%)
2A 45 (0.2%)
3A 59 (0.3%)
T o t a l T w i n 1 B2 B3 B
1A 700 (3.1%)
2A 135 (0.6%)
3A 192 (0.9%)
Between pair Twin 2A 2B
Total 1A 791 (3.6%)
3A 1251 (5.9%)
3B 1150 (5.6%) 1114 (5.2%)
* Decrease or increase is referred to 1B, 2B and 3B who had higher BMD than 1A, 2A and 3A respectively.
Table 3: Numbers of probe sets showing decrease or increase of the three most frequent gene ontology (GO) molecular function in 
each pair's comparison. 2A/2B and 3A/3B are the discordant pair for BMD, and 1A/1B is the concordant pair.
GO molecular function* No of probe sets
1A/1B Decrease** All 417
5488 159
3824 91
4871 85
Increase** All 283
5488 111
3824 69
4871 45
2A/2B Decrease All 90
5488 35
4871 20
3824 17
Increase All 45
5488 18
3824 6
4871 6
3A/3B Decrease All 133
5488 53
3824 27
4871 15
Increase All 59
5488 23
3824 11
4871 10
* Gene ontology molecular function terms are: 5488 – binding activity; 3824 – enzyme activity and 4871 – signal transducer activity. ** Decrease or 
increase is referred to 1B, 2B and 3B who had higher BMD than 1A, 2A and 3A respectively.BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/14
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increased expression in both the discordant case pairs but
not the concordant pair – this was chondroitin beta 1,4 N-
acetylgalactosaminyltransferase (ChGn, NM_018371), a
gene which regulates an important reaction in cartilage
synthesis.
The probe sets in Table 2 were submitted to the NetAffx
Centre for gene ontology (GO) analysis. Results are
shown in Table 3. The patterns of GO molecular functions
for decrease or increase in the three pairs are very similar
with about 80% of the probe sets categorized under 3 GO
terms: 5488 binding activity, 3824 enzyme activity and
4871 signal transducer activity. Hierarchy maps showed
nodes branched out from these 3 main GO terms also had
similar patterns for the three pairs (data not shown).
However there were nodes with several probe sets
grouped especially to the 2A/2B and 3A/3B case pairs but
not in 1A/1B control pair. These nodes were 5125
cytokine activity, 8083 growth factor activity, 5194 cell
adhesion molecular activity and 3700 transcription factor
activity (Table 4). These molecular functions which might
involve bone physiology included cytokine/growth fac-
tors, transcription factors and cell adhesion molecules.
We have also performed between pair comparisons: 1A/
2A, 2A/3B, 2B/3A and 2B/3B. As expected the number of
probe sets showing at least 2 fold changes were higher
than the within pair comparisons. The numbers of
changes for 1A/2A, 2A/3B, 2B/3A and 2B/3B were 791,
1150, 1251 and 1114 respectively or 3.6, 5.6, 5.9 and
5.2% (Table 2). GO analysis of these probe sets, the same
3 GO terms (5488 binding activity, 3824 enzyme activity
and 4871 signal transducer activity) came out as the com-
monest molecular functions annotated. The GO molecu-
lar functions, which found with the discordant case pairs
but not the concordant control pair (Table 4), were
present in the hierarchy maps in all 4 between pair com-
parisons (data not shown).
Table 4: List of genes grouped under gene ontology molecular functions that showed changes in the discordant monozygotic (MZ) twin 
pairs but not the concordant pair.
Probe Set ID Gene Name Fold changed Gene Symbol
5125 Cytokine activity in 2A/2B decrease
204926_at inhibin, beta A (activin A, activin AB alpha polypeptide) 2.1 INHBA
205067_at interleukin 1, beta 4.3 IL1B
205476_at* chemokine (C-C motif) ligand 20 3.0 CCL20
205767_at Epiregulin 3.3 EREG
206569_at interleukin 24 3.3 IL24
210557_x_at colony stimulating factor 1 (macrophage) 2.1 CSF1
211839_s_at colony stimulating factor 1 (macrophage) 2.8 CSF1
221577_x_at* prostate differentiation factor 2.3 PLAB
39402_at interleukin 1, beta 4.0 IL1B
8083 Growth factor activity in 2A/2B decrease
204926_at inhibin, beta A (activin A, activin AB alpha polypeptide) 2.1 INHBA
205067_at interleukin 1, beta 4.3 IL1B
205767_at Epiregulin 3.3 EREG
210557_x_at colony stimulating factor 1 (macrophage) 2.1 CSF1
211839_s_at colony stimulating factor 1 (macrophage) 2.8 CSF1
221577_x_at* prostate differentiation factor 2.3 PLAB
39402_at interleukin 1, beta 4.0 IL1B
5194 Cell adhesion molecular activity in 2A/2B increase
202877_s_at complement component 1, q subcomponent, receptor 1 2.0 C1QR1
203477_at collagen, type XV, alpha 1 2.0 COL15A1
204677_at** cadherin 5, type 2, VE-cadherin (vascular epithelium) 5.7 CDH5
208983_s_at** platelet/endothelial cell adhesion molecule (CD31 antigen) 3.5 PECAM1
212713_at microfibrillar-associated protein 4 3.7 MFAP4
3700 Transcription factor activity in 3A/3B decrease
207034_s_at GLI-Kruppel family member GLI2 2.0 GLI2
207147_at distal-less homeo box 2 2.6 DLX2
208003_s_at nuclear factor of activated T-cells 5, tonicity-responsive 3.3 NFAT5
208859_s_at alpha thalassemia/mental retardation syndrome X-linked (RAD54 
homolog, S. cerevisiae)
2.8 ATRX
209088_s_at ubinuclein 1 2.1 UBN1
212420_at E74-like factor 1 (ets domain transcription factor) 2.1 ELF1BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/14
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Discussion
We have performed a genome-wide gene expression study
on 6 RNA samples extracted from primary osteoblast-like
cultures prepared from 3 pairs of MZ twins ascertained for
BMD. The gene expression is expected to be very similar if
not identical within pairs because MZ twins should for
practical purposes be 100% genetically identical and their
tissue type should have the same expression profile.
Indeed in the 2A/2B and 3A/3B case pairs, despite being
discordant for BMD at the hip, the percentage of probe
sets showing alteration more than 2 folds were only 0.6
and 0.9% respectively (Table 2), in other words the gene
expression was over 99% similar. This less than 1% differ-
ence in expression in the osteoblast-like cells is likely to be
due to the discordance in BMD. However paradoxically
the control pair 1A/1B who were concordant for BMD
showed more variation – 3.1%, or about 97% similar.
There is little data in the literature to compare, but a very
recent publication [8] found 3.2% of genes showed
expression changes of more than 2 folds for a single MZ
twin pair discordant for multiple myeloma. The authors
used Affymetrix hu95av2, which tested smaller number of
genes than the Affymetrix human U133A chip we used,
and the experimental conditions might be different as
well. Nevertheless it showed that variation could be up to
3%. Another report using lymphoblastoid cells from 35
unrelated individuals [7], who are parents from the Cen-
tre d'Etude du Polymorphism Humain (CEPH), showed
15.7% (814 out of 5184) genes were significantly variable
in expression. The 3.1% gene variation of the 1A/1B con-
trol pair is much lower than this unrelated individuals' fig-
ure of 15.7%. The 1A/1B pair is concordant for BMD, but
they could be discordant for other phenotypes or environ-
mental factors not recorded by us, or this might reflect
normal variation in both in vivo gene expression and
microarray assay.
The majority (about 80%) of changes within the three
pairs fall into 3 GO molecular terms (Table 3) – 5488
binding activity, 3824 enzyme activity and 4871 signal
transducer activity, and in fact the hierarchy maps are
similar in terms of the branches of nodes. It has been sug-
gested that allelic differences might underlie gene expres-
sion variations [9]. But as MZ pairs should not have any
allelic differences, hence it is possible that the genes of
these 3 GO terms could express differently independent of
polymorphisms of the genetic sequences, and possibly
regulated by external, environmental or epigenetic factors.
It will be of interest to find out whether the gene expres-
sion pattern in other tissue types is similar or not. If as
likely this were a universal pattern for different types of
tissues, it would suggest those differentially expressed
genes are possibly regulated by external non-heritable
genetic factors.
Exploring the hierarchy maps in more detail, there are par-
ticular nodes in the discordant case pairs with several
probe sets grouped under them (Table 4), and these nodes
are either absent from the control pair, or contain only
one or two probe sets. As the two case pairs are discordant
for bone density, it is of interest that these genes are all
related to bone physiology. The first group of genes
belong to cytokine and growth factors showing decrease
in 2A/2B, they are the inhibin beta A (also known as
activin A, activin AB alpha polypeptide) (INHBA) inter-
leukin 1 beta (IL1B) and colony stimulating factor 1 mac-
rophage (CSF1). For IL1B and CSF1, two probe sets for
each gene showed consistent decrease strongly suggesting
a genuine change was there. In fact, allelic variations of
the IL1B gene have been reported to be associated with
BMD and osteoporosis [10] and with osteoarthitis [11,12]
a common joint disease which has associated sub-chon-
dral bone changes and increased bone turnover and bone
mass [13]. Mutations in the CSF1 gene can cause severe
215698_at retinoblastoma binding protein 2 2.1 RBBP2
3700 Transcription factor activity in 3A/3B increase
205991_s_at paired mesoderm homeo box 1 2.0 PMX1
207001_x_at delta sleep inducing peptide, immunoreactor 2.0 DSIPI
207558_s_at paired-like homeodomain transcription factor 2 3.7 PITX2
208502_s_at paired-like homeodomain transcription factor 1 8.6 PITX1
210135_s_at short stature homeobox 2 7.5 SHOX2
221950_at empty spiracles homolog 2 (Drosophila) 4.3 EMX2
5194 Cell adhesion activity in 3A/3B increase
204677_at cadherin 5, type 2, VE-cadherin (vascular epithelium) 3.5 CDH5
208983_s_at platelet/endothelial cell adhesion molecule (CD31 antigen) 2.6 PECAM1
* Also show decrease in 1A/1B pair but the changes were less than 2 folds ** Also show increase in 3A/3B pair
Table 4: List of genes grouped under gene ontology molecular functions that showed changes in the discordant monozygotic (MZ) twin 
pairs but not the concordant pair. (Continued)BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/14
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osteoporosis in rats [14-16]. It has also shown that INHBA
may play crucial roles in the transformation of osteopro-
genitor cells to osteoblasts during bone and bone marrow
regeneration [17].
The second group of genes belong to transcription factors
showing both increase and decrease in 3A/3B (Table 4).
They are mainly homeo-box genes. The next group of
genes are cell adhesion molecules such as the collagen
type XV alpha 1 (COL15A1), cadherin 5 type 2 VE-cad-
herin (vascular epithelium) (CDH5) and platelet/
endothelial cell adhesion molecule (CD31 antigen)
(PECAM1) showing increase in both the case pairs. It has
been shown that several homeo box genes together with
different cell adhesion genes initiate skeletal development
[18]. Furthermore, collagen type XV like other collagens is
an important component for skeletal muscle and bone
[19]. Additionally we also noted that expression of the
chondroitin beta 1,4 N-acetylgalactosaminyltransferase
(ChGn) gene was increased in both case pairs but not the
control pair. ChGn is the key enzyme in chondronitin sul-
phate biosynthesis [20,21] and therefore relates directly to
cartilage formation, which is important in osteoarthritis, a
related disease to osteoporosis.
All the probe sets and genes mentioned above showed
more than 2 fold changes in expression between at least
one of the case pairs, but not in the control pair. Whilst
failure to replicate expression variations between the case
pairs might reflect spurious results or false positives or
negatives, it is also possible that there is genetic heteroge-
neity for BMD discordance in the two discordant case
pairs. Indeed the 3A/3B was discordant for both the hip
and spine (Table 1), whilst 2A/2B was discordant for the
hip. If this were the case we might observe different genes
whose expressions altered, and finding explanatory genes
using this method could be more difficult than antici-
pated. Nevertheless the genes we highlighted are docu-
mented to have effects on bone physiology and could be
influencing different BMD within the MZ twins.
Apart from comparing gene expression within pairs for
the microarray results, we have performed between-pair
comparisons. This is equivalent to comparing between
unrelated individuals. As expected there were more gene
expression changes than when comparing within pairs, on
average 5% for between pairs as compared to 1.5% for
within pairs (Table 2). However the overall patterns were
consistent with the same 3 GO molecular terms showing
most changes. From the hierarchy maps, 5125 cytokine
activity, 8083 growth factor activity and 5194 cell adhe-
sion molecular activity, the three GO molecular terms that
present in discordant BMD case pairs but not the concord-
ant control pair, were present in all four comparisons
between the MZ pairs, basically unrelated individuals.
This is not a surprise finding as cytokine, growth factor
and cell adhesion molecules are associated and functions
in a great variety of metabolic pathways, and would show
changes in gene expression between unrelated individuals
[7]. This further supports that the use of MZ twin pairs
could select genes related to phenotypic differences
efficiently.
Due to the limited amount of RNA samples obtained
from primary culture, we could not perform the microar-
ray experiments in duplicate or triplicate and therefore
statistical and clustering analyses, which might give a bet-
ter indication of the expression changes. For the same rea-
son, we could not carry out further RNA analysis such as
Northern blot and real time polymerase chain reaction to
confirm our results. However we have performed the
microarray experiments not for only one pair of MZ twins,
as most previous reports did, but in 3 pairs of the same age
with one as the control pair. Hopefully our results could
be generalizable to cases of similar bone density differ-
ences. A replication study to confirm our results is
essential.
There is little previous data on the use of MZ twins in gene
discovery. One report in the literature using T cells from
one MZ twin pair discordant for type I diabetes demon-
strated that the interleukin-4 excretion was impaired in
the diabetic cotwin and correlated to difference in gene
expression [6,22]. In another report, one disease gene
mutation has been pinpointed with the use of one MZ
twin pair – this was one of the rare forms of cleft palate
(van der Woude Syndrome) [23]. Our study is more
detailed than these studies, and examined more genes in
a common phenotypic trait.
We have identified 10 hip BMD discordant pairs out of
200. Seven of them with identifiable environmental con-
founders were excluded. These 7 pairs could have been
studied in the same way looking for genes that were either
influenced by environmental factors or resulted from the
discordance in BMD. Although not the primary aim of the
present study, it would be a useful idea for further studies
looking for possible causative genes. Twin registries
around the world have collected tens of thousands twin
pairs with detailed phenotypes recorded, it would cost no
extra to find discordant MZ twin pairs to study despite
their relative rarity.
Conclusion
In conclusion, with the latest expression chip of over
20,000 genes, it is possible to examine genome-wide gene
expression. Using the example of osteoblast-like cells in
our MZ twins discordant for BMD at hip, we obtained
promising results – indicating that whilst 99% of
expressed genes are similar, several identified genes show-BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/14
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ing different expressions within pairs have potential roles
in bone physiology. Although without further experi-
ment, we cannot confirm or conclude these are the genes
definitely related to BMD, we believe we have shown the
potential and cost-effectiveness of further gene expression
studies using discordant MZ twins.
Methods
Twin pairs were selected from a panel of 400 unselected
adult female MZ twins for discordance of BMD at the hip
using a Hologic QDR 4500 densitometer. Pairs were
excluded if there was an obvious environmental cause for
the discordance such as smoking, anorexia, bulimia,
amenorrhea or chronic diseases like colitis, surgical men-
opause, use of bone drugs and alcoholism. At least one of
the twin pair had to be close to the World Health Organi-
zation definition of osteoporosis – namely being 2.5
standard deviations (SD) below the peak bone mass of an
average 30 year-old (called T-score).
Following ethical approval from the St Thomas' Hospital
Ethics committee with verbal and written consent, bone
marrow aspirates from the iliac crest were obtained from
three pairs of female MZ twins. The bone marrow sample
was added to 25 ml of heparinised serum-free Dulbecco's
Modified Eagle Medium (DMEM). Twenty ml of Ficoll-
Hypaque were layered on top of the bone marrow suspen-
sion and centrifuged at 600 g for 30 minutes. Mononu-
clear cells at the interface were harvested and washed. The
cells were counted and plated out under basal conditions
in DMEM containing 15% foetal calf serum and 100 µM
ascorbate-2-phosphate. The cells were seeded at the same
density, 104 cells per cm2. After 28 days, cell proliferation
and the total number of colonies were determined. The
colony forming units (CFU's) were stained for alkaline
phosphatase (ALP) and the percentage of ALP positive
CFU's were derived. All experiments were done in quadru-
plicate. Flow cytometric analysis (FACS) was carried out
to demonstrate the pattern of expression of the stromal
cell marker STRO1 and ALP.
RNA was also extracted from the primary cell culture at
confluence after 21 – 28 days using the Trizol method
(Invitrogen, Paisley UK) according to the manufacturer's
protocol. The six RNA samples were sent to the Medical
Research Council (MRC) Geneservice of Human Genome
Mapping Project – Resource Center at Cambridge, UK for
microarray assay using Affymetrix Human U133A micro-
chip. Experimental information can be found at the MRC
Geneservice RNA Services web page [24]. Results within
the same pair were compared using the Microarray Suite
5.0 (MAS5) software. The probe sets that showed decrease
or increase between the paired samples with a signal ratio
of equal or larger than 1.0 (that means the decrease or
increase change is equal to or larger than 2 folds) were
submitted to the Netaffx Analysis Centre of the Affymetrix
Website [25] for analysis by the Gene Ontology Miming
Tool [26]. There are 22,283 probe sets on each Human
U133A microchip of which 13,615 are annotated with
molecular function for the gene ontology.
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